- Home
- PRLD vs MKTW Comparison
PRLD vs MKTW Comparison
Compare PRLD & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- MKTW
- Stock Information
- Founded
- PRLD 2016
- MKTW 1999
- Country
- PRLD United States
- MKTW United States
- Employees
- PRLD N/A
- MKTW N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- MKTW Computer Software: Prepackaged Software
- Sector
- PRLD Health Care
- MKTW Technology
- Exchange
- PRLD Nasdaq
- MKTW Nasdaq
- Market Cap
- PRLD 50.1M
- MKTW 48.2M
- IPO Year
- PRLD 2020
- MKTW N/A
- Fundamental
- Price
- PRLD $0.88
- MKTW $17.49
- Analyst Decision
- PRLD Strong Buy
- MKTW
- Analyst Count
- PRLD 2
- MKTW 0
- Target Price
- PRLD $4.50
- MKTW N/A
- AVG Volume (30 Days)
- PRLD 168.1K
- MKTW 17.0K
- Earning Date
- PRLD 08-11-2025
- MKTW 08-13-2025
- Dividend Yield
- PRLD N/A
- MKTW 4.16%
- EPS Growth
- PRLD N/A
- MKTW 207.28
- EPS
- PRLD N/A
- MKTW 3.12
- Revenue
- PRLD $7,000,000.00
- MKTW $383,217,000.00
- Revenue This Year
- PRLD N/A
- MKTW N/A
- Revenue Next Year
- PRLD N/A
- MKTW N/A
- P/E Ratio
- PRLD N/A
- MKTW $5.60
- Revenue Growth
- PRLD N/A
- MKTW N/A
- 52 Week Low
- PRLD $0.61
- MKTW $9.08
- 52 Week High
- PRLD $6.80
- MKTW $27.10
- Technical
- Relative Strength Index (RSI)
- PRLD 48.33
- MKTW 53.83
- Support Level
- PRLD $0.85
- MKTW $17.15
- Resistance Level
- PRLD $1.25
- MKTW $18.28
- Average True Range (ATR)
- PRLD 0.10
- MKTW 0.76
- MACD
- PRLD -0.02
- MKTW -0.22
- Stochastic Oscillator
- PRLD 18.52
- MKTW 44.60
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.